241 related articles for article (PubMed ID: 28763307)
21. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study.
Dietrich SK; Rowe S; Cocchio CA; Harmon AJ; Nerenberg SF; Blankenship PS
Ann Pharmacother; 2021 Aug; 55(8):980-987. PubMed ID: 33305592
[TBL] [Abstract][Full Text] [Related]
23. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
[TBL] [Abstract][Full Text] [Related]
24. Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience.
Mačiukaitienė J; Bilskienė D; Tamašauskas A; Bunevičius A
Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344253
[No Abstract] [Full Text] [Related]
25. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
Edavettal M; Rogers A; Rogers F; Horst M; Leng W
Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
[TBL] [Abstract][Full Text] [Related]
26. Modified version of the American College of Cardiology's recommendation for low-dose prothrombin complex concentrate is effective for warfarin reversal.
Gilbert BW; Morton L; Huffman JB; Roemer K; Potter A; Cassidy CD; Vasquez DG
Am J Emerg Med; 2020 Apr; 38(4):806-809. PubMed ID: 31864879
[TBL] [Abstract][Full Text] [Related]
27. Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation.
Enter DH; Zaki AL; Marsh M; Cool N; Kruse J; Li Z; Andrei AC; Iddriss A; McCarthy PM; Malaisrie SC; Anderson A; Rich JD; Pham DT
Pharmacotherapy; 2017 Oct; 37(10):1215-1220. PubMed ID: 28833357
[TBL] [Abstract][Full Text] [Related]
28. Obesity increases risk of anticoagulation reversal failure with prothrombin complex concentrate in those with intracranial hemorrhage.
Chu C; Tokumaru S; Izumi K; Nakagawa K
Int J Neurosci; 2016; 126(1):62-6. PubMed ID: 25430740
[TBL] [Abstract][Full Text] [Related]
29. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.
Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I
Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927
[TBL] [Abstract][Full Text] [Related]
30. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal.
Baggs JH; Patanwala AE; Williams EM; Erstad BL
Ann Pharmacother; 2012 Jan; 46(1):51-6. PubMed ID: 22190253
[TBL] [Abstract][Full Text] [Related]
31. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
Huynh TK; Costello JL; Rebuck JA
Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA
Thromb Haemost; 2011 Dec; 106(6):1215-23. PubMed ID: 22071880
[TBL] [Abstract][Full Text] [Related]
33. Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage.
Corio JL; Sin JH; Hayes BD; Goldstein JN; Fuh L
West J Emerg Med; 2018 Sep; 19(5):849-854. PubMed ID: 30202498
[TBL] [Abstract][Full Text] [Related]
34. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
Stewart WS; Pettit H
Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
[TBL] [Abstract][Full Text] [Related]
35. Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal.
Voils SA; Holder MC; Premraj S; Catlin JR; Allen BR
Thromb Res; 2015 Sep; 136(3):595-8. PubMed ID: 26233569
[TBL] [Abstract][Full Text] [Related]
36. 3-Factor Versus 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Severe Bleeding: A Multicenter, Retrospective, Propensity-Matched Pilot Study.
Jones GM; Erdman MJ; Smetana KS; Mohrien KM; Vandigo JE; Elijovich L
J Thromb Thrombolysis; 2016 Jul; 42(1):19-26. PubMed ID: 26721625
[TBL] [Abstract][Full Text] [Related]
37. Using prothrombin complex concentrates to rapidly reverse oral anticoagulant effects.
Dager WE
Ann Pharmacother; 2011 Jul; 45(7-8):1016-20. PubMed ID: 21775688
[TBL] [Abstract][Full Text] [Related]
38. Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate.
Peksa GD; Mokszycki RK; Rech MA; Maynard B; Panos NG; Sweis RT; DeMott JM
Thromb Haemost; 2020 Feb; 120(2):207-215. PubMed ID: 31837652
[TBL] [Abstract][Full Text] [Related]
39. Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal.
Rowe AS; Dietrich SK; Phillips JW; Foster KE; Canter JR
Crit Care Med; 2018 Jun; 46(6):943-948. PubMed ID: 29498942
[TBL] [Abstract][Full Text] [Related]
40. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.
Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ
Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
